Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.30 is 383% above its 5-year average of 2.13, near the high end of its 5-year range (0.02–14.21).
As of the fiscal period ended Tuesday, June 30, 2026. 61.62% above its 12-month average of 6.38.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.30.
QUICK RATIO (ACID-TEST)
10.30
QUICK RATIO (ACID-TEST) AVG TTM
6.38
QUICK RATIO (ACID-TEST) AVG 3Y
2.51
QUICK RATIO (ACID-TEST) AVG 5Y
2.13
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+61.62%
CURRENT VS 3Y AVG
+310.05%
CURRENT VS 5Y AVG
+383.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.33
median of 858 covered companies
CURRENT VS SECTOR MEDIAN
+208.95%
vs the sector median at left
Market Cap
$4.12M
Quick Ratio (Acid-Test)
1.78
TTM Avg
2.64
3Y Avg
1.92
5Y Avg
1.57
Market Cap
$4.02M
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.77
3Y Avg
2.83
5Y Avg
2.68
Market Cap
$4.20M
Quick Ratio (Acid-Test)
0.87
TTM Avg
1.88
3Y Avg
4.97
5Y Avg
8.67
Market Cap
$4.30M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.83
3Y Avg
3.75
5Y Avg
3.40
Market Cap
$4.34M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.51M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$3.63M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | $4.09M | 10.30 | 6.38 | 2.51 | 2.13 |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $4.12M | 1.78 | 2.64 | 1.92 | 1.57 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.02M | 2.08 | 2.77 | 2.83 | 2.68 |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.20M | 0.87 | 1.88 | 4.97 | 8.67 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.30M | 1.95 | 2.83 | 3.75 | 3.40 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | 1.35 | 3.30 | 6.18 | 6.77 |
| Evogene Ltd. (EVGN)vs › | $3.79M | 3.54 | 2.77 | 4.28 | 5.12 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.51M | 2.73 | 3.29 | 4.75 | 4.47 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.63M | 2.01 | 0.91 | 1.26 | 1.78 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 3.73 | 3.25 | 4.33 | 4.33 |
Quick Ratio
10.30
Excludes inventory
Current Ratio
10.30
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.30 |
| 2026-04-30 | 14.21 |
| 2026-01-31 | 3.25 |
| 2025-10-31 | 1.70 |
| 2025-07-31 | 2.41 |
| 2025-04-30 | 1.41 |
| 2025-01-31 | 3.43 |
| 2024-10-31 | 3.10 |
| 2024-07-31 | 3.11 |
| 2024-04-30 | 2.64 |
| 2024-01-31 | 1.09 |
| 2023-09-30 | 2.01 |
| 2023-06-30 | 3.49 |
| 2023-03-31 | 1.02 |
| 2022-12-31 | 0.16 |
| 2022-09-30 | 0.02 |
| 2022-06-30 | 1.81 |
| 2022-03-31 | 2.27 |
| 2021-12-31 | 3.32 |
| 2021-09-30 | 7.55 |
| 2021-06-30 | 6.82 |
| 2021-03-31 | 5.91 |
| 2020-12-31 | 0.30 |
| 2020-09-30 | 0.92 |
| 2020-06-30 | 1.74 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 4.86 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
